Gal-3 levels were higher in the mild LAM group with AML compared to no AML suggesting AMLs were an additional source of serum Gal-3 (Figure 6H- and Figure 6—source data 2 and 3). The gene discussed is LGALS3; the disease is lymphangioleiomyomatosis.